{"transactions":[{"id":854625,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2026-03-09T22:13:36.000Z","date":"2026-03-07","kind":"exercise","planned":false,"acquired":false,"shares":12223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the March 7, 2023 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2033-03-07","underlying":"Common Stock","underlying_shares":12223},"source":{"system":"sec-edgar","filing":"0001104659-26-025369","document":"tm268290-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926025369/tm268290-6_4seq1.xml","form_type":"4"}},{"id":854624,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2026-03-09T22:13:36.000Z","date":"2026-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":5904,"price":9.98,"value":58921.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":130599,"source":{"system":"sec-edgar","filing":"0001104659-26-025369","document":"tm268290-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926025369/tm268290-6_4seq1.xml","form_type":"4"}},{"id":854623,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2026-03-09T22:13:36.000Z","date":"2026-03-07","kind":"exercise","planned":false,"acquired":true,"shares":12223,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":136503,"source":{"system":"sec-edgar","filing":"0001104659-26-025369","document":"tm268290-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926025369/tm268290-6_4seq1.xml","form_type":"4"}},{"id":854622,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Non-statutory Stock Option NQ","published_at":"2026-03-09T22:12:20.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":194000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This Form 4/A has been filed solely to amend the exercise price as originally reported in Column 2 and price of derivative security in Column 8 of Table II of the Reporting Person's Form 4 filed on March 3, 2026. All other information remains unchanged from the March 3, 2026 filing."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4/A has been filed solely to amend the exercise price as originally reported in Column 2 and price of derivative security in Column 8 of Table II of the Reporting Person's Form 4 filed on March 3, 2026. All other information remains unchanged from the March 3, 2026 filing."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":194000,"derivative":{"exercise_price":10.11,"expiration_date":"2036-03-03","underlying":"Common Stock","underlying_shares":194000},"source":{"system":"sec-edgar","filing":"0001104659-26-025368","document":"tm268290-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926025368/tm268290-5_4seq1.xml","form_type":"4/A","original_submission_date":"2026-03-03"}},{"id":859560,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T11:04:04.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":43167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on each of the first three (3) anniversaries of March 1, 2024, in each case subject to continued employment through such vesting date."}],"balance_after":86333,"derivative":{"exercise_price":0,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":43167},"source":{"system":"sec-edgar","filing":"0001104659-26-023731","document":"tm268076-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023731/tm268076-4_4seq1.xml","form_type":"4"}},{"id":859559,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2026-03-05T11:04:04.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":20850,"price":9.49,"value":197866.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":124280,"source":{"system":"sec-edgar","filing":"0001104659-26-023731","document":"tm268076-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023731/tm268076-4_4seq1.xml","form_type":"4"}},{"id":859558,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2026-03-05T11:04:04.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":43167,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":145130,"source":{"system":"sec-edgar","filing":"0001104659-26-023731","document":"tm268076-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023731/tm268076-4_4seq1.xml","form_type":"4"}},{"id":870561,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Non-statutory Stock Option NQ","published_at":"2026-03-04T02:35:40.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":194000,"price":9.09,"value":1763460.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-quarter (1/4) of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":194000,"derivative":{"exercise_price":9.09,"expiration_date":"2036-03-03","underlying":"Common Stock","underlying_shares":194000},"source":{"system":"sec-edgar","filing":"0001104659-26-023072","document":"tm267953-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023072/tm267953-3_4seq1.xml","form_type":"4"}},{"id":870560,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2026-03-04T02:35:40.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":129500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of March 2, 2026, in each case subject to continued employment through such vesting date."}],"balance_after":129500,"derivative":{"exercise_price":0,"expiration_date":"2036-03-03","underlying":"Common Stock","underlying_shares":129500},"source":{"system":"sec-edgar","filing":"0001104659-26-023072","document":"tm267953-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023072/tm267953-3_4seq1.xml","form_type":"4"}},{"id":870559,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2026-03-04T02:35:40.000Z","date":"2026-03-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":58666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, (the \"Plan\") vest on each of the first three (3) anniversaries of March 1, 2024, in each case subject to continued employment through such vesting date."}],"balance_after":58666,"derivative":{"exercise_price":0,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":58666},"source":{"system":"sec-edgar","filing":"0001104659-26-023072","document":"tm267953-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023072/tm267953-3_4seq1.xml","form_type":"4"}},{"id":870558,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2026-03-04T02:35:40.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":28366,"price":10.14,"value":287631.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":101963,"source":{"system":"sec-edgar","filing":"0001104659-26-023072","document":"tm267953-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023072/tm267953-3_4seq1.xml","form_type":"4"}},{"id":870557,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2026-03-04T02:35:40.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":true,"shares":58666,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":130299,"source":{"system":"sec-edgar","filing":"0001104659-26-023072","document":"tm267953-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023072/tm267953-3_4seq1.xml","form_type":"4"}},{"id":1213263,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2025-03-11T20:33:46.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":false,"shares":12223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the March 7, 2023 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":12223,"derivative":{"exercise_price":0,"exercise_date":"2024-03-07","expiration_date":"2033-03-07","underlying":"Common Stock","underlying_shares":12223},"source":{"system":"sec-edgar","filing":"0001593968-25-000332","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000332/primary_01.xml","form_type":"4"}},{"id":1213262,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2025-03-11T20:33:46.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":5904,"price":8.34,"value":49239.36,"ownership":{"direct":true},"balance_after":69251,"source":{"system":"sec-edgar","filing":"0001593968-25-000332","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000332/primary_01.xml","form_type":"4"}},{"id":1213261,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2025-03-11T20:33:46.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":true,"shares":12223,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":75155,"source":{"system":"sec-edgar","filing":"0001593968-25-000332","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000332/primary_01.xml","form_type":"4"}},{"id":1224130,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"2025 Restricted Stock Units RSU","published_at":"2025-03-05T22:01:11.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":129500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date."}],"balance_after":129500,"derivative":{"exercise_price":0,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":129500},"source":{"system":"sec-edgar","filing":"0001593968-25-000302","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000302/primary_01.xml","form_type":"4"}},{"id":1224129,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"2025 Non-statutory Stock Option NQ","published_at":"2025-03-05T22:01:11.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":194500,"price":7.87,"value":1530715.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":194500,"derivative":{"exercise_price":7.87,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":194500},"source":{"system":"sec-edgar","filing":"0001593968-25-000302","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000302/primary_01.xml","form_type":"4"}},{"id":1231753,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2025-03-04T23:43:04.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":false,"shares":58667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date."}],"balance_after":117333,"derivative":{"exercise_price":0,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":58667},"source":{"system":"sec-edgar","filing":"0001593968-25-000287","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000287/primary_01.xml","form_type":"4"}},{"id":1231752,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2025-03-04T23:43:04.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":28337,"price":8.33,"value":236047.21,"ownership":{"direct":true},"balance_after":62932,"source":{"system":"sec-edgar","filing":"0001593968-25-000287","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000287/primary_01.xml","form_type":"4"}},{"id":1231751,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2025-03-04T23:43:04.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":58667,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":91269,"source":{"system":"sec-edgar","filing":"0001593968-25-000287","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000287/primary_01.xml","form_type":"4"}},{"id":1316523,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2025-01-03T22:41:48.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vest with respect to one-half (1/2) of the RSUs on each of the first two (2) anniversaries of the grant date, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2033-09-12","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001593968-25-000029","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000029/primary_01.xml","form_type":"4"}},{"id":1316522,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2025-01-03T22:41:48.000Z","date":"2024-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":16906,"price":8.04,"value":135924.24,"ownership":{"direct":true},"balance_after":32602,"source":{"system":"sec-edgar","filing":"0001593968-25-000029","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000029/primary_01.xml","form_type":"4"}},{"id":1316521,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2025-01-03T22:41:48.000Z","date":"2024-12-31","kind":"exercise","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":49508,"source":{"system":"sec-edgar","filing":"0001593968-25-000029","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000029/primary_01.xml","form_type":"4"}},{"id":1428219,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2024-08-20T21:06:20.000Z","date":"2024-08-16","kind":"exercise","planned":false,"acquired":false,"shares":2367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2031-08-16","underlying":"Common Stock","underlying_shares":2367},"source":{"system":"sec-edgar","filing":"0001593968-24-001088","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824001088/primary_01.xml","form_type":"4"}},{"id":1428218,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2024-08-20T21:06:20.000Z","date":"2024-08-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":1223,"price":12.96,"value":15850.08,"ownership":{"direct":true},"balance_after":14429,"source":{"system":"sec-edgar","filing":"0001593968-24-001088","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824001088/primary_01.xml","form_type":"4"}},{"id":1428217,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"officer":true,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2024-08-20T21:06:20.000Z","date":"2024-08-16","kind":"exercise","planned":false,"acquired":true,"shares":2367,"price":12.96,"value":30676.32,"ownership":{"direct":true},"balance_after":15652,"source":{"system":"sec-edgar","filing":"0001593968-24-001088","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824001088/primary_01.xml","form_type":"4"}},{"id":1561110,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & Treasurer"}}],"security":"Restricted Stock Units","published_at":"2024-03-26T23:01:36.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":176000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":176000,"derivative":{"underlying":"Common Stock","underlying_shares":176000},"source":{"system":"sec-edgar","filing":"0001104659-24-039164","document":"tm249879-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924039164/tm249879-4_4seq1.xml","form_type":"4"}},{"id":1582184,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2024-03-13T00:46:41.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":false,"shares":4608,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 10, 2022 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 10, 2022 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":4608,"derivative":{"underlying":"Common Stock","underlying_shares":4608},"source":{"system":"sec-edgar","filing":"0001104659-24-033621","document":"tm248710-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924033621/tm248710-3_4seq1.xml","form_type":"4"}},{"id":1582183,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2024-03-13T00:46:41.000Z","date":"2024-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2226,"price":5.45,"value":12131.7,"ownership":{"direct":true},"balance_after":13285,"source":{"system":"sec-edgar","filing":"0001104659-24-033621","document":"tm248710-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924033621/tm248710-3_4seq1.xml","form_type":"4"}},{"id":1582182,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2024-03-13T00:46:41.000Z","date":"2024-03-10","kind":"exercise","planned":false,"acquired":true,"shares":4608,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":15511,"source":{"system":"sec-edgar","filing":"0001104659-24-033621","document":"tm248710-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924033621/tm248710-3_4seq1.xml","form_type":"4"}},{"id":1584997,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2024-03-12T01:39:24.000Z","date":"2024-03-07","kind":"exercise","planned":false,"acquired":false,"shares":12224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 7, 2023 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 7, 2023 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":24446,"derivative":{"underlying":"Common Stock","underlying_shares":12224},"source":{"system":"sec-edgar","filing":"0001104659-24-033163","document":"tm248549-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924033163/tm248549-1_4seq1.xml","form_type":"4"}},{"id":1584996,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2024-03-12T01:39:24.000Z","date":"2023-09-12","kind":"grant","planned":false,"acquired":false,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, will vest in full as of December 31, 2024, subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, will vest in full as of December 31, 2024, subject to continued employment through such vesting date."}],"balance_after":35000,"derivative":{"underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001104659-24-033163","document":"tm248549-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924033163/tm248549-1_4seq1.xml","form_type":"4"}},{"id":1584995,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2024-03-12T01:39:24.000Z","date":"2024-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":5905,"price":5.61,"value":33127.05,"ownership":{"direct":true},"balance_after":10903,"source":{"system":"sec-edgar","filing":"0001104659-24-033163","document":"tm248549-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924033163/tm248549-1_4seq1.xml","form_type":"4"}},{"id":1584994,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2024-03-12T01:39:24.000Z","date":"2024-03-07","kind":"exercise","planned":false,"acquired":true,"shares":12224,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":16808,"source":{"system":"sec-edgar","filing":"0001104659-24-033163","document":"tm248549-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924033163/tm248549-1_4seq1.xml","form_type":"4"}},{"id":1802382,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2023-08-18T20:37:36.000Z","date":"2023-08-16","kind":"exercise","planned":false,"acquired":false,"shares":2366,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the August 16, 2021 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the August 16, 2021 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":2367,"derivative":{"underlying":"Common Stock","underlying_shares":2366},"source":{"system":"sec-edgar","filing":"0001209191-23-046569","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123046569/doc4.xml","form_type":"4"}},{"id":1802381,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2023-08-18T20:37:36.000Z","date":"2023-08-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":1143,"price":7.13,"value":8149.59,"ownership":{"direct":true},"balance_after":4584,"source":{"system":"sec-edgar","filing":"0001209191-23-046569","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123046569/doc4.xml","form_type":"4"}},{"id":1802380,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2023-08-18T20:37:36.000Z","date":"2023-08-16","kind":"exercise","planned":false,"acquired":true,"shares":2366,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":5727,"source":{"system":"sec-edgar","filing":"0001209191-23-046569","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123046569/doc4.xml","form_type":"4"}},{"id":1955185,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2023-03-14T21:19:10.000Z","date":"2023-03-10","kind":"exercise","acquired":false,"shares":4609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 10, 2022 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the March 10, 2022 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":9216,"derivative":{"underlying":"Common Stock","underlying_shares":4609},"source":{"system":"sec-edgar","filing":"0001209191-23-018550","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123018550/doc4.xml","form_type":"4"}},{"id":1955184,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2023-03-14T21:19:10.000Z","date":"2023-03-10","kind":"tax_withholding","acquired":false,"shares":2471,"price":6.52,"value":16110.92,"ownership":{"direct":true},"balance_after":3361,"source":{"system":"sec-edgar","filing":"0001209191-23-018550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123018550/doc4.xml","form_type":"4"}},{"id":1955183,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2023-03-14T21:19:10.000Z","date":"2023-03-10","kind":"exercise","acquired":true,"shares":4609,"price":6.52,"value":30050.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were received by the reporting person in connection with vesting of restricted stock units (\"RSUs\")."}],"balance_after":5832,"source":{"system":"sec-edgar","filing":"0001209191-23-018550","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123018550/doc4.xml","form_type":"4"}},{"id":1961629,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2023-03-09T22:01:36.000Z","date":"2023-03-07","kind":"grant","acquired":true,"shares":36670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date."}],"balance_after":36670,"derivative":{"underlying":"Common Stock","underlying_shares":36670},"source":{"system":"sec-edgar","filing":"0001209191-23-017584","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123017584/doc4.xml","form_type":"4"}},{"id":1961628,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-09T22:01:36.000Z","date":"2023-03-07","kind":"grant","acquired":true,"shares":42350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), will vest on the first anniversary of the March 7, 2023 grant date (the \"Grant Date\"), and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date."}],"balance_after":42350,"derivative":{"exercise_price":6.97,"exercise_date":"2024-03-07","expiration_date":"2033-03-07","underlying":"Common Stock","underlying_shares":42350},"source":{"system":"sec-edgar","filing":"0001209191-23-017584","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123017584/doc4.xml","form_type":"4"}},{"id":2180078,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2022-08-18T21:02:40.000Z","date":"2022-08-16","kind":"exercise","acquired":false,"shares":2367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the August 16, 2021 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested or will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the August 16, 2021 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":4733,"derivative":{"underlying":"Common Stock","underlying_shares":2367},"source":{"system":"sec-edgar","filing":"0001209191-22-046687","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122046687/doc4.xml","form_type":"4"}},{"id":2180077,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2022-08-18T21:02:40.000Z","date":"2022-08-16","kind":"tax_withholding","acquired":false,"shares":1144,"price":42.88,"value":49054.72,"ownership":{"direct":true},"balance_after":1223,"source":{"system":"sec-edgar","filing":"0001209191-22-046687","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122046687/doc4.xml","form_type":"4"}},{"id":2180076,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Common Stock","published_at":"2022-08-18T21:02:40.000Z","date":"2022-08-16","kind":"exercise","acquired":true,"shares":2367,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."}],"balance_after":2367,"source":{"system":"sec-edgar","filing":"0001209191-22-046687","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122046687/doc4.xml","form_type":"4"}},{"id":2336253,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2022-03-14T23:48:53.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":13825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date."}],"balance_after":13825,"derivative":{"underlying":"Common Stock","underlying_shares":13825},"source":{"system":"sec-edgar","filing":"0001209191-22-018659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122018659/doc4.xml","form_type":"4"}},{"id":2336252,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-14T23:48:53.000Z","date":"2022-03-10","kind":"grant","acquired":true,"shares":20737,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), will vest on the first anniversary of the March 10, 2022 grant date (the \"Grant Date\"), and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date."}],"balance_after":20737,"derivative":{"exercise_price":77.77,"expiration_date":"2032-03-10","underlying":"Common Stock","underlying_shares":20737},"source":{"system":"sec-edgar","filing":"0001209191-22-018659","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919122018659/doc4.xml","form_type":"4"}},{"id":2598624,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-18T21:16:43.000Z","date":"2021-08-16","kind":"grant","acquired":true,"shares":14200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Twenty-five percent (25%) of the shares subject to this option grant under the Plan will vest on the first anniversary of the Grant Date, and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date."}],"balance_after":14200,"derivative":{"exercise_price":229.31,"expiration_date":"2031-08-16","underlying":"Common Stock","underlying_shares":14200},"source":{"system":"sec-edgar","filing":"0001209191-21-052263","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121052263/doc4.xml","form_type":"4"}},{"id":2598623,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO and Treasurer"}}],"security":"Restricted Stock Units","published_at":"2021-08-18T21:16:43.000Z","date":"2021-08-16","kind":"grant","acquired":true,"shares":7100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Novavax, Inc. (the \"Company\") common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), will vest on each of the first three (3) anniversaries of the August 16, 2021 grant date (the \"Grant Date\"), subject to continued employment through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended (the \"Plan\"), will vest on each of the first three (3) anniversaries of the August 16, 2021 grant date (the \"Grant Date\"), subject to continued employment through each such vesting date."}],"balance_after":7100,"derivative":{"underlying":"Common Stock","underlying_shares":7100},"source":{"system":"sec-edgar","filing":"0001209191-21-052263","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919121052263/doc4.xml","form_type":"4"}},{"id":2838641,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice-President & CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-23T23:55:16.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on February 19, 2022."}],"balance_after":15000,"derivative":{"exercise_price":29.61,"expiration_date":"2031-02-19","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-21-026940","document":"tm217706d11_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465921026940/tm217706d11_4seq1.xml","form_type":"4"}},{"id":3007997,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Vice-President & CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-10-13T16:03:24.000Z","date":"2020-10-12","kind":"grant","acquired":true,"shares":135000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on October 12, 2021."}],"balance_after":135000,"derivative":{"exercise_price":21.13,"expiration_date":"2030-10-12","underlying":"Common Stock","underlying_shares":135000},"source":{"system":"sec-edgar","filing":"0001104659-20-114367","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356576/000110465920114367/a4.xml","form_type":"4"}},{"id":3226808,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-04T22:01:37.000Z","date":"2020-03-03","kind":"sale","acquired":false,"shares":5889,"price":10.7589,"value":63359.1621,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.60 to $11.0001, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":186869,"source":{"system":"sec-edgar","filing":"0001209191-20-016200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919120016200/doc4.xml","form_type":"4"}},{"id":3226807,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-04T22:01:37.000Z","date":"2020-03-02","kind":"sale","acquired":false,"shares":12968,"price":10.1856,"value":132086.8608,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.10 to $10.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":192758,"source":{"system":"sec-edgar","filing":"0001209191-20-016200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919120016200/doc4.xml","form_type":"4"}},{"id":3317725,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-06T22:25:41.000Z","date":"2020-01-02","kind":"sale","acquired":false,"shares":4020,"price":15.9418,"value":64086.036,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to a written election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.81 to $16.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":205726,"source":{"system":"sec-edgar","filing":"0001209191-20-002029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919120002029/doc4.xml","form_type":"4"}},{"id":3618263,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-03-04T22:06:31.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":8751,"price":19.879,"value":173961.129,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.76 to $20.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":209746,"source":{"system":"sec-edgar","filing":"0001209191-19-015737","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119015737/doc4.xml","form_type":"4"}},{"id":3618262,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-03-04T22:06:31.000Z","date":"2019-03-01","kind":"sale","acquired":false,"shares":4976,"price":20.151,"value":100271.376,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.06 to $20.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":218497,"source":{"system":"sec-edgar","filing":"0001209191-19-015737","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119015737/doc4.xml","form_type":"4"}},{"id":3622886,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-01T21:19:47.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in forty-eight (48) equal monthly installments from the date of grant, provided the Reporting Person remains continuously employed by the Issuer through each vesting date."}],"balance_after":70000,"derivative":{"exercise_price":20.62,"expiration_date":"2029-02-26","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-19-014970","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119014970/doc4.xml","form_type":"4"}},{"id":3622885,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-03-01T21:19:47.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (\"RSU\"). The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2020, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."}],"balance_after":223473,"source":{"system":"sec-edgar","filing":"0001209191-19-014970","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119014970/doc4.xml","form_type":"4"}},{"id":3703338,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-01-04T21:33:18.000Z","date":"2019-01-03","kind":"sale","acquired":false,"shares":1619,"price":26.085,"value":42231.615,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.00 to $26.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4."}],"balance_after":193473,"source":{"system":"sec-edgar","filing":"0001209191-19-001986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119001986/doc4.xml","form_type":"4"}},{"id":3703337,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-01-04T21:33:18.000Z","date":"2019-01-02","kind":"sale","acquired":false,"shares":1129,"price":26.939,"value":30414.131,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.89 to $26.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":195092,"source":{"system":"sec-edgar","filing":"0001209191-19-001986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119001986/doc4.xml","form_type":"4"}},{"id":3703336,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-01-04T21:33:18.000Z","date":"2019-01-02","kind":"sale","acquired":false,"shares":3313,"price":26.31,"value":87165.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.87 to $26.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":196221,"source":{"system":"sec-edgar","filing":"0001209191-19-001986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919119001986/doc4.xml","form_type":"4"}},{"id":4019406,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-03-02T22:34:50.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests in forty-eight (48) equal monthly installments beginning on February 28, 2018, provided the Reporting Person remains continuously employed by the Issuer through each  vesting date."}],"balance_after":80000,"derivative":{"exercise_price":18.85,"expiration_date":"2028-02-27","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001209191-18-015882","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118015882/doc4.xml","form_type":"4"}},{"id":4019405,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-02T22:34:50.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":8532,"price":18.7192,"value":159712.2144,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs as reflected in this Form 4. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The Reporting The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.35 to $18.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":199534,"source":{"system":"sec-edgar","filing":"0001209191-18-015882","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118015882/doc4.xml","form_type":"4"}},{"id":4019404,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-02T22:34:50.000Z","date":"2018-02-28","kind":"grant","acquired":true,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (\"RSU\"). The RSU vests in four (4) equal annual installments beginning February 28, 2019, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."}],"balance_after":208066,"source":{"system":"sec-edgar","filing":"0001209191-18-015882","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118015882/doc4.xml","form_type":"4"}},{"id":4106908,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-01-04T22:12:32.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive a share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The RSUs vest in four (4) equal annual installments beginning January 1, 2017, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Not Applicable."}],"balance_after":15000,"derivative":{"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-18-002060","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118002060/doc4.xml","form_type":"4"}},{"id":4106907,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-01-04T22:12:32.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive a share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The RSUs vest in four (4) equal annual installments beginning January 1, 2016, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Not Applicable."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-002060","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118002060/doc4.xml","form_type":"4"}},{"id":4106906,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-01-04T22:12:32.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive a share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSUs vest in four (4) equal annual installments beginning January 1, 2015, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Not Applicable."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-002060","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118002060/doc4.xml","form_type":"4"}},{"id":4106905,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-04T22:12:32.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":9155,"price":15.3461,"value":140493.5455,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs as reflected in this Form 4. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.30 to $15.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (7) to this Form 4."}],"balance_after":168066,"source":{"system":"sec-edgar","filing":"0001209191-18-002060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118002060/doc4.xml","form_type":"4"}},{"id":4106904,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-04T22:12:32.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Each RSU was previously reported on Table II on a Form 4 filed with the SEC on February 17, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive a share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Starting with the January 2, 2018 vesting of the RSUs, the Issuer's method of reporting RSUs has been revised to report such grants in Table I rather than as previously reported in Table II. Accordingly, the share numbers reported in Column 5 of Table I includes unvested RSUs previously reported in Table II."}],"balance_after":177221,"source":{"system":"sec-edgar","filing":"0001209191-18-002060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118002060/doc4.xml","form_type":"4"}},{"id":4106903,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-04T22:12:32.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Each RSU was previously reported on Table II on a Form 4 filed with the SEC on December 5, 2014."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive a share of the Issuer's Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Starting with the January 2, 2018 vesting of the RSUs, the Issuer's method of reporting RSUs has been revised to report such grants in Table I rather than as previously reported in Table II. Accordingly, the share numbers reported in Column 5 of Table I includes unvested RSUs previously reported in Table II."}],"balance_after":154721,"source":{"system":"sec-edgar","filing":"0001209191-18-002060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118002060/doc4.xml","form_type":"4"}},{"id":4106902,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-04T22:12:32.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") was previously reported on Table II on a Form 4 filed with the Securities and Exchange Commission (\"SEC\") on December 4, 2013."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive a share of the Issuer's Common Stock."}],"balance_after":144721,"source":{"system":"sec-edgar","filing":"0001209191-18-002060","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919118002060/doc4.xml","form_type":"4"}},{"id":4402812,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-03-03T22:31:51.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option shall vest in forty-eight (48) equal monthly installments beginning March 1, 2017, provided Reporting Person remains continuously employed by the Issuer through each monthly vesting date."}],"balance_after":70000,"derivative":{"exercise_price":14.5,"expiration_date":"2027-02-28","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001209191-17-017798","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919117017798/doc4.xml","form_type":"4"}},{"id":4402811,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2017-03-03T22:31:51.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":70000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units (\"RSU\") shall vest in four (4) equal annual installments beginning March 1, 2018, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissable Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive a share of the Issuer's common stock."}],"balance_after":139721,"source":{"system":"sec-edgar","filing":"0001209191-17-017798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919117017798/doc4.xml","form_type":"4"}},{"id":4497861,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2017-01-05T22:01:56.000Z","date":"2017-01-03","kind":"exercise","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive a share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The RSUs shall vest in four (4) equal annual installments beginning January 1, 2017, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not Applicable."}],"balance_after":22500,"derivative":{"underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-17-002200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919117002200/doc4.xml","form_type":"4"}},{"id":4497860,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2017-01-05T22:01:56.000Z","date":"2017-01-03","kind":"exercise","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive a share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs shall vest in four (4) equal annual installments beginning January 1, 2016, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not Applicable."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-17-002200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919117002200/doc4.xml","form_type":"4"}},{"id":4497859,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2017-01-05T22:01:56.000Z","date":"2017-01-03","kind":"exercise","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive a share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs shall vest in four (4) equal annual installments beginning January 1, 2015, provided Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not Applicable."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-17-002200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919117002200/doc4.xml","form_type":"4"}},{"id":4497858,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Restricted Stock Unit","published_at":"2017-01-05T22:01:56.000Z","date":"2017-01-03","kind":"exercise","acquired":true,"shares":2344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive a share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"50% of the original RSU award vested on July 29, 2013 due to milestone achievement, the remaining RSUs vest in four (4) equal annual installments beginning January 1, 2014, provided Reporting Person has remained in continuous service with the Issuer on each applicable vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not Applicable."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2344},"source":{"system":"sec-edgar","filing":"0001209191-17-002200","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919117002200/doc4.xml","form_type":"4"}},{"id":4497857,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Common Stock","published_at":"2017-01-05T22:01:56.000Z","date":"2017-01-03","kind":"sale","acquired":false,"shares":10895,"price":15.5129,"value":169013.0455,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs as reflected in this Form 4. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The Reporting The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.35 to $15.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4."}],"balance_after":69721,"source":{"system":"sec-edgar","filing":"0001209191-17-002200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919117002200/doc4.xml","form_type":"4"}},{"id":4497856,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Common Stock","published_at":"2017-01-05T22:01:56.000Z","date":"2017-01-03","kind":"exercise","acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive a share of the Issuer's common stock."}],"balance_after":80616,"source":{"system":"sec-edgar","filing":"0001209191-17-002200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919117002200/doc4.xml","form_type":"4"}},{"id":4497855,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Common Stock","published_at":"2017-01-05T22:01:56.000Z","date":"2017-01-03","kind":"exercise","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive a share of the Issuer's common stock."}],"balance_after":73116,"source":{"system":"sec-edgar","filing":"0001209191-17-002200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919117002200/doc4.xml","form_type":"4"}},{"id":4497854,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Common Stock","published_at":"2017-01-05T22:01:56.000Z","date":"2017-01-03","kind":"exercise","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive a share of the Issuer's common stock."}],"balance_after":68116,"source":{"system":"sec-edgar","filing":"0001209191-17-002200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919117002200/doc4.xml","form_type":"4"}},{"id":4497853,"issuer":{"id":5861,"kind":"organization","name":"Vanda Pharmaceuticals Inc."},"owners":[{"id":62131,"kind":"person","name":"Kelly James Patrick","position":1,"cik":"0001506314","reported_name":"Kelly James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CFO & Treasurer"}}],"security":"Common Stock","published_at":"2017-01-05T22:01:56.000Z","date":"2017-01-03","kind":"exercise","acquired":true,"shares":2344,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive a share of the Issuer's common stock."}],"balance_after":63116,"source":{"system":"sec-edgar","filing":"0001209191-17-002200","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347178/000120919117002200/doc4.xml","form_type":"4"}}]}